The SPEX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SPEX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SPEX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SPEX Detailed Price Forecast - CNN Money||View SPEX Detailed Summary - Google Finance|
|View SPEX Detailed Summary - Yahoo! Finance||View SPEX Stock Research & Analysis - Zacks.com|
|View SPEX Trends & Analysis - Trade-Ideas||View SPEX Major Holders - Barrons|
|View SPEX Call Transcripts - NASDAQ||View SPEX Breaking News & Analysis - Seeking Alpha|
|View SPEX Annual Report - CompanySpotlight.com||View SPEX OTC Short Report - OTCShortReport.com|
|View SPEX Fundamentals - TradeKing||View SPEX SEC Filings - Bar Chart|
|View Historical Prices for SPEX - The WSJ||View Performance/Total Return for SPEX - Morningstar|
|View the Analyst Estimates for SPEX - MarketWatch||View the Earnings History for SPEX - CNBC|
|View the SPEX Earnings - StockMarketWatch||View SPEX Buy or Sell Recommendations - MacroAxis|
|View the SPEX Bullish Patterns - American Bulls||View SPEX Short Pain Metrics - ShortPainBot.com|
|View SPEX Stock Mentions - StockTwits||View SPEX Stock Mentions - PennyStockTweets|
|View SPEX Stock Mentions - Twitter||View SPEX Investment Forum News - Investor Hub|
|View SPEX Stock Mentions - Yahoo! Message Board||View SPEX Stock Mentions - Seeking Alpha|
|View Insider Transactions for SPEX - SECform4.com||View Insider Transactions for SPEX - Insider Cow|
|View SPEX Major Holdings Summary - CNBC||View Insider Disclosure for SPEX - OTC Markets|
|View Insider Transactions for SPEX - Yahoo! Finance||View Institutional Holdings for SPEX - NASDAQ|
|View SPEX Stock Insight & Charts - FinViz.com||View SPEX Investment Charts - StockCharts.com|
|View SPEX Stock Overview & Charts - BarChart||View SPEX User Generated Charts - Trading View|
Spherix Announces Preclinical Pancreatic Cancer Treatment Study Moving Forward
Posted on Tuesday November 27, 2018
NEW YORK, Nov. 27, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) today announced the funding of a study for KPC34, for pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDA). PDA is considered the deadliest of major cancers and patients are in desperate need of improved therapies. PDA is caused by chronic inflammatory stress associated with the increasingly common afflictions of obesity, type 2 diabetes, and pancreatitis, exacerbated by smoking and drinking. KPC34 is a candidate therapeutic because it is activated preferentially inside tumor cells to release an inhibitor of DNA replication and a separate tumor promotion inhibitor. Annually, more than 350,000 new cases of pancreatic cancer are diagnosed across the world. According to the American Society of Clinical Oncology, a six-month course of gemcitabine, the chemotherapy drug typically used to treat advanced pancreatic cancer, costs about $23,500.
Today's Research Reports on Trending Tickers: Twilio and Spherix
Posted on Tuesday November 27, 2018
NEW YORK, NY / ACCESSWIRE / November 27, 2018 / Twilio shares were on the rise on an “outperform” rating reiterated from an Oppenheimer analyst last week while Spherix Incorporated shares popped on news ...
Spherix Announces Ownership Interest in Electric Scooter Business
Posted on Monday November 26, 2018
From renting out an unused road bike, to running a fleet of hundreds of electric scooters, Mellow provides a flexible entry for anyone interested in the growing shared vehicles space. Additional information about the investment will be available in the Form 8-K, filed by Spherix with the Securities and Exchange Commission.
Spherix Announces the Addition of Dr. Rana Quraishi to Company's Advisory Board
Posted on Monday October 29, 2018
NEW YORK, Oct. 29, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) today announced that it has added Dr. Rana Quraishi to the Company's Advisory Board to assist the Company in evaluating potential opportunities in the biopharmaceutical area. Dr. Rana Quraishi is the Director of New Ventures, at UM Ventures University of Maryland, Baltimore. UM Ventures is a joint initiative bringing the University of Maryland, Baltimore and University of Maryland, College Park together to commercialize discoveries and create economic impact by engaging partners in industry and social ventures. Dr. Quraishi has a Ph.D. in Molecular Biology and Biochemistry from Columbia University where she was also an undergraduate and an M.S. from Harvard University.